Point-of-Care Diabetes Monitoring via Breath Acetone Detection by Priefer, Ronny & Rust, Michael
University of Massachusetts Medical School 
eScholarship@UMMS 
UMass Center for Clinical and Translational 
Science Research Retreat 
2014 UMass Center for Clinical and 
Translational Science Research Retreat 
May 20th, 12:30 PM 
Point-of-Care Diabetes Monitoring via Breath Acetone Detection 
Ronny Priefer 
Western New England University 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/cts_retreat 
 Part of the Biomedical Devices and Instrumentation Commons, Diagnosis Commons, Equipment and 
Supplies Commons, Nutritional and Metabolic Diseases Commons, and the Translational Medical 
Research Commons 
Priefer R, Rust M. (2014). Point-of-Care Diabetes Monitoring via Breath Acetone Detection. UMass Center 
for Clinical and Translational Science Research Retreat. Retrieved from 
https://escholarship.umassmed.edu/cts_retreat/2014/posters/128 
Creative Commons License 
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 License. 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in UMass Center for 
Clinical and Translational Science Research Retreat by an authorized administrator of eScholarship@UMMS. For 
more information, please contact Lisa.Palmer@umassmed.edu. 
Point-of-Care Diabetes Monitoring via Breath Acetone Detection  
Ronny Priefer,1 Michael Rust2 
 
1 Department of Pharmaceutical & Administrative Science, Western New England University, 
Springfield, MA 
2 Department of Biomedical Engineering, Western New England University, Springfield, MA 
Western New England University 
ronny.priefer@wne.edu 
 
 
Purpose 
Diabetes can be a life-long disease which requires continuous blood-glucose monitoring. 
Currently technology, albeit good, does have its draw-backs; in particular that it is an invasive 
technique which causes discomfort to the individual. Therefore, low compliance can ultimately 
lead to other health issues. Approaches are underway to develop a portable, hand-held, 
noninvasive monitoring device to detect the biomarker, acetone, found in the breath of diabetics. 
By creating films of poly(4-vinylbenzeneboronic acid) and poly(allylamine hydrochloride), 
acetone can react with these via a Petasis reaction. This alters the physicochemical nature of 
the film, providing a quantification of acetone, and thus hopefully blood-glucose levels, in a non-
invasive manner. 
 
Methods 
UV-transmitting poly(methyl methacrylate) slides are coated with a system of PAH/PVBBA at 
differing pH values and are then exposed to acetone/water vapor. Concentrations of acetone 
evaluated are 0.1–10 ppm.  The slides are next subjected to the light emitted by a diode with a 
peak wavelength of 300 ± 5 nm. The transmitted light is detected by a UV-photosensor with an 
integrated transimpedance amplifier that produces a voltage output as a function of absorption.  
 
Results 
We have successfully synthesized poly(4-vinylbenzeneboronic acid) and multilayered with 
poly(allylamine hydrochloride). We have been able to cross-link these two polymers using only 
acetone vapor and are developing a hand-held device. Analyzing the difference in output 
voltage from exposed to unexposed slides at varying acetone concentrations, provides is a 
linear relationship up to 2500 ppb, which is above the high point for breath acetone 
concentration. 
 
Conclusions 
We have been able to develop a technology that accurately detects acetone vapor. We are 
engineering a hand-held breathalyzer device to detect acetone in the breath of diabetic 
individuals and are attempting to optimize its capabilities. 
 
 
 
